Adventitious agents, new technology, and risk assessment, 19-20 May 2011, Baltimore, MD.

Abstract In May 2011, the International Alliance for Biological Standardization, with the cooperation of WHO, FDA, and NIAID, organized a conference on adventitious agents that might be found in biological products using new technology ( http://www.iabs.org/index.php/past-conference-reports/116-baltimore-2011-slides ). The implications of such findings on risk assessment also were considered. Topics that were addressed included: a) current routine testing – what are we doing now?; b) recent advances in testing – what tests are being explored/applied?; c) examples of finding agents with “new” techniques; and d) risk assessment, including recent WHO activities. A draft algorithm for risk assessment was discussed in terms of its applicability to a variety of potential new agents and the possibilities for improving it.